TrialBlood2016
Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma.
Torben Plesner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
60 papers cite it
this paperpooled ittrialcites it
TrialBlood2016
Torben Plesner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.